INBIOGEN Co., Ltd. (KRX:101140)
South Korea · Delayed Price · Currency is KRW 12,640
+170 (1.36%)
At close: Sep 4, 2025
INBIOGEN Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 15,029 | 16,122 | 11,344 | -117,218 | 94,125 | -45,078 | Upgrade |
Depreciation & Amortization | 718.06 | 1,057 | 1,224 | 1,438 | 1,117 | 443.42 | Upgrade |
Loss (Gain) From Sale of Assets | -31.29 | 168.14 | 65.35 | - | 138.43 | 40.8 | Upgrade |
Asset Writedown & Restructuring Costs | 992.37 | 992.37 | - | - | - | 76.67 | Upgrade |
Loss (Gain) From Sale of Investments | 1.06 | 1.04 | -39,032 | 178,976 | -123,863 | -14,050 | Upgrade |
Loss (Gain) on Equity Investments | -20,057 | -21,538 | 32,458 | -42,777 | 5,062 | 19,726 | Upgrade |
Provision & Write-off of Bad Debts | 85.41 | 146.46 | 129.11 | -73.23 | 361.64 | 0.58 | Upgrade |
Other Operating Activities | 1,012 | 929.23 | -8,551 | -29,527 | 18,627 | 35,293 | Upgrade |
Change in Accounts Receivable | -2,370 | -115.2 | 2,583 | 1,718 | -2,088 | -5,154 | Upgrade |
Change in Inventory | 189.21 | 66.65 | -605.69 | -835.19 | -450.99 | 407 | Upgrade |
Change in Accounts Payable | 188.3 | 218.13 | -233.19 | -412.39 | -60.71 | 735.19 | Upgrade |
Change in Other Net Operating Assets | 1,718 | 1,918 | -432.25 | -2,794 | -37.39 | -474.02 | Upgrade |
Operating Cash Flow | -2,523 | -33.13 | -1,051 | -11,505 | -7,069 | -8,033 | Upgrade |
Capital Expenditures | -98.4 | -84.28 | -25.96 | -130.68 | -2,360 | -427.91 | Upgrade |
Sale of Property, Plant & Equipment | 71.24 | 10.05 | 73.81 | 29.84 | 4.6 | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | -305 | -200 | -41.15 | -543.16 | Upgrade |
Investment in Securities | - | - | 64.43 | -15,664 | -38,000 | -4,895 | Upgrade |
Other Investing Activities | 411.34 | 0 | 0 | 0 | - | 0 | Upgrade |
Investing Cash Flow | 384.18 | -74.23 | -192.72 | -15,925 | -40,437 | -5,866 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 15,000 | 35,000 | Upgrade |
Total Debt Issued | - | - | - | - | 15,000 | 35,000 | Upgrade |
Long-Term Debt Repaid | - | -265.3 | -1,895 | -28,432 | -777.72 | -20,030 | Upgrade |
Total Debt Repaid | -220.91 | -265.3 | -1,895 | -28,432 | -777.72 | -20,030 | Upgrade |
Net Debt Issued (Repaid) | -220.91 | -265.3 | -1,895 | -28,432 | 14,222 | 14,970 | Upgrade |
Issuance of Common Stock | - | - | - | 12,000 | - | - | Upgrade |
Repurchase of Common Stock | - | - | -62.49 | - | - | - | Upgrade |
Other Financing Activities | - | - | -0 | - | -0 | 0 | Upgrade |
Financing Cash Flow | -220.91 | -265.3 | -1,957 | 13,568 | 61,543 | 14,970 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -0 | -0 | - | -0 | - | Upgrade |
Net Cash Flow | -2,360 | -372.65 | -3,201 | -13,862 | 14,038 | 1,072 | Upgrade |
Free Cash Flow | -2,622 | -117.41 | -1,077 | -11,636 | -9,430 | -8,461 | Upgrade |
Free Cash Flow Margin | -33.88% | -1.67% | -17.25% | -111.67% | -89.97% | -82.80% | Upgrade |
Free Cash Flow Per Share | - | -11.76 | -126.51 | -3209.03 | -3155.62 | -4093.39 | Upgrade |
Cash Interest Paid | 38.27 | 0.03 | 10.7 | 142.04 | 220.28 | 1,074 | Upgrade |
Cash Income Tax Paid | - | -0.26 | -11.3 | 1.41 | -13.53 | -114.21 | Upgrade |
Levered Free Cash Flow | -2,775 | -1,145 | -1,660 | -16,530 | -8,817 | -10,815 | Upgrade |
Unlevered Free Cash Flow | -2,734 | -1,113 | -1,496 | -14,226 | -6,423 | -6,920 | Upgrade |
Change in Working Capital | -273.84 | 2,088 | 1,312 | -2,324 | -2,637 | -4,485 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.